Demoncheaux E A G, Higenbottam T W, Foster P J, Borland C D R, Smith A P L, Marriott H M, Bee D, Akamine S, Davies M B
Academic Unit of Respiratory Medicine, Division of Clinical Sciences (South), Floor F, Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, U.K.
Clin Sci (Lond). 2002 Jan;102(1):77-83.
Inhaled nitric oxide (NO) is a pulmonary vasodilator, but also acts systemically, causing negative cardiac inotropic effects and a fall in systemic vascular resistance. Circulating metabolites of NO are presumed to be responsible. We questioned the role of nitrite anions and the manner in which they might contribute to these effects. Nitrite and nitrate anions coexist in blood, while circulating levels of dissolved NO are very low. Nitrate anions are not biologically active, but nitrite anions may have a biological role through the release of NO. In vitro, at 37 degrees C and in aerated Krebs bicarbonate solution, the steady-state concentration of dissolved NO was proportional to the concentration of NO in the gas. Nanomolar concentrations of dissolved NO coexisted with micromolar concentrations of nitrite anions. The idea of an equilibrium between the two in solution was also supported by the observed release of NO from nitrite anions in the absence of gas. With rings of precontracted pig pulmonary arteries (prostaglandin F(2alpha); 10 micromol/l), the steady-state concentration of dissolved NO causing 50% relaxation (EC(50)) was 0.84+/-0.25 nmol/l, corresponding to a gaseous concentration of 2.2 p.p.m. The EC(50) of nitrite was 4.5+/-0.7 micromol/l, a concentration normally found in plasma. The estimated concentration of dissolved NO derived from this nitrite was 4.5 pmol/l, some 100 times lower than would be needed to cause relaxation. The rate of exhalation of NO was increased and pulmonary vascular resistance was reduced by the addition of nitrite solution to the perfusate of isolated perfused and ventilated pig lungs, but only when millimolar concentrations were achieved. Thus circulating nitrite anions are a direct vasodilator, only being a carrier of effective amounts of "free" NO at higher than physiological concentrations.
吸入一氧化氮(NO)是一种肺血管扩张剂,但也会产生全身作用,导致负性心肌收缩力效应并使全身血管阻力下降。推测其循环代谢产物是造成这些影响的原因。我们对亚硝酸根阴离子的作用以及它们可能导致这些效应的方式提出了疑问。亚硝酸根阴离子和硝酸根阴离子共存于血液中,而溶解态NO的循环水平非常低。硝酸根阴离子没有生物活性,但亚硝酸根阴离子可能通过释放NO发挥生物学作用。在体外,37℃且通有空气的 Krebs 碳酸氢盐溶液中,溶解态NO的稳态浓度与气体中NO的浓度成正比。纳摩尔浓度的溶解态NO与微摩尔浓度的亚硝酸根阴离子共存。在没有气体的情况下,从亚硝酸根阴离子中观察到NO的释放,这也支持了溶液中两者之间存在平衡的观点。对于预先收缩的猪肺动脉环(前列腺素F(2α);10微摩尔/升),引起50%舒张(EC(50))的溶解态NO的稳态浓度为0.84±0.25纳摩尔/升,对应气态浓度为2.2 ppm。亚硝酸的EC(50)为4.5±0.7微摩尔/升,这是血浆中通常存在的浓度。由此亚硝酸衍生的溶解态NO的估计浓度为4.5皮摩尔/升,比引起舒张所需浓度低约100倍。向离体灌注和通气的猪肺灌注液中添加亚硝酸盐溶液会增加NO的呼出速率并降低肺血管阻力,但只有达到毫摩尔浓度时才会出现这种情况。因此,循环中的亚硝酸根阴离子是一种直接血管扩张剂,仅在高于生理浓度时才是有效量“游离”NO的载体。